Robert J Myerson, Elesyia D Outlaw, Albert Chang, Elisa H Birnbaum, James W Fleshman, Perry W Grigsby, Ira J Kodner, Robert S Malayapa, Matthew G Mutch, Parag Parikh, Joel Picus, Benjamin R Tan
PURPOSE: To evaluate the factors associated with disease control and morbidity after radiotherapy for anal carcinoma. METHODS AND MATERIALS: Between 1975 and 2005, 194 patients with localized epidermoid anal carcinoma underwent radiotherapy. Treatment evolved from radiotherapy with or without surgery, to preoperative chemoradiotherapy, to definitive chemoradiotherapy (CRT). The radiotherapy techniques also evolved. RESULTS: With a median follow-up of 61 months, 57 patients had persistence or recurrence, 9 of whom were successfully salvaged, resulting in 146 (75%) ultimately free of disease (UNED)...
October 1, 2009: International Journal of Radiation Oncology, Biology, Physics